China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd.

200028.SZ
China National Accord Medicines Corporation Ltd.CN flagShenzhen Stock Exchange
11.90
HKD
+0.05
- -
12.66BMarket Cap

China National Accord Medicines Corporation Ltd. (200028.SZ) Stock Split History

Learn about China National Accord Medicines Corporation Ltd.'s most recent 11-for-10 basis stock split on June 26, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about China National Accord Medicines Corporation Ltd.'s most recent stock split

Split Date: 2026-06-26
Split Ratio: 11:10
Price Before Split: $12.87
Price After Split: $11.70

Developer API

Get 200028.SZ split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/200028.SZ

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.10 times more shares (a 11:10 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of China National Accord Medicines Corporation Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-06-2611:10No$12.87$11.70
2026-06-2411:10No$14.53$13.21
2023-06-0113:10No$21.17$16.29
2000-09-119:5NoN/AN/A
1996-11-126:5NoN/AN/A
1996-07-1621:20NoN/AN/A
1995-09-0111:10NoN/AN/A
1994-08-3111:10NoN/AN/A

About China National Accord Medicines Corporation Ltd.

Company overview and industry information

China National Accord Medicines Corporation Ltd. (200028.SZ) operates in the Medical - Distribution industry. The recent 11-for-10 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Medical - Distribution
Go to China National Accord Medicines Corporation Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.